$VRDN
Viridian Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$19.00
▼-2.06%-$0.400
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateViridian Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is VRDN down today? It is at $19.00 (-2.06%), and our scanner flagged it 104 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment VRDN spikes, and full due diligence on VRDN — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $VRDN 104 times in the last 30 days. Create a free account to track $VRDN, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on VRDN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for VRDN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystViridian Therapeutics, Inc.\DE: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Tousignant Jennifer Officer | Sold (automatic/other) | -14K 0.01% of company | n/a | n/a | $348K at $24.50 | Aug 19, 26 |
Tousignant Jennifer Officer | Other | 10K | n/a | 10K | $144K at $14.41 | Aug 19, 26 |
Tripuraneni Radhika Officer | Other | 40K 0.04% of company | n/a | 40K | $528K at $13.21 | Aug 14, 26 |
Fairmount Funds Management Llc Director | Bought (open market) | +1.18M 1.0% of company | added 30% | 5.09M | $20.0M at $17.00 | May 11, 26 |
Mahoney Stephen F. Officer | Sold (automatic/other) | -8K | sold 19% | 33K | $224K at $29.32 | Mar 3, 26 |
Mahoney Stephen F. Officer | Other | 18K 0.02% of company | added 82% | 41K | n/a | Mar 3, 26 |
Beetham Thomas W. Officer | Sold (automatic/other) | -3K | sold 19% | 13K | $92K at $29.32 | Mar 3, 26 |
Beetham Thomas W. Officer | Other | 9K | added 100% | 16K | n/a | Mar 3, 26 |
Harmon Seth Officer | Sold (automatic/other) | -2K | sold 21% | 8K | $61K at $29.32 | Mar 3, 26 |
Harmon Seth Officer | Other | 6K | added 100% | 10K | n/a | Mar 3, 26 |
Tousignant Jennifer Officer | Sold (automatic/other) | -2K | sold 33% | 3K | $51K at $29.32 | Mar 3, 26 |
Tousignant Jennifer Officer | Other | 5K | n/a | 5K | n/a | Mar 3, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on VRDN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for VRDN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
VRDN last traded at $19.00, down 2.06% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Viridian Therapeutics, Inc. Common Stock (VRDN) is next expected to report earnings on Wednesday, November 4, 2026, about 29 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The VRDN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged VRDN 104 times in the last 30 days.
VRDN (Viridian Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $2.15B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge VRDN for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$VRDN discussion
Sign in to ask a question or join the discussion.